Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Pathophysiology

Cancer Management

Cancer Symptoms

What is Merkel Cell Carcinoma?

Cancer Prognosis

Exploiting Enzymes in Cancer Diagnosis and Therapy

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Insights into Oncofertility

Insight into Cancer Vaccines

What Role do Biobanks Play in Cancer Research?

Transforming Cancer Care through Genomic Testing

See more featured articles »

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer History

What is Cancer of Unknown Primary?

What is Tumorigenesis?

Cancer Pain Management

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Pain

Cancer Diagnosis

Extracellular Vesicles as Floating Cancer Biomarkers

Myc Mutations and Cancer

Cancer Research

Using Biomarkers to Detect Cancer

Cancer Epidemiology

Is Cancer a Metabolic Disorder?

The Effects of Cancer on Family Life

Cancer Glossary

British Pioneers in Cancer Biology

Hot vs Cold: the differences between tumor types

What is Immunochemotherapy?

CDK9 and Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cutaneous Manifestations of Internal Malignancy

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Assay for Monitoring and Treating Malignant Brain Tumors

The Cancer Cell Surface Proteome as a Therapeutic Target

Secondary Brain Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Biochemistry of Breast Cancer Screening

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Pediatric Cancer

Investigating the Molecular Mechanisms of Cancer

Overview of Cell Viability and Cytotoxicity

Why are Cancer Cell Lines Useful?

Cancer Classification

Effects of Social and Economic Deprivation on Cancer Mortality

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

TARDIS: The Improved Method of Detecting Breast Cancer

Targeted Cancer Therapies

Acidosis and Tumor Progression

Caring for a Loved One with Cancer

Hypoxia Markers and Their Importance

Microfluidic cancer treatment screen combined with flow cytometry

What is the Tumor Microenvironment?

Living with Cancer Pain

Secondary Lung Cancer

What Causes Cancer?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Cancer?

Cancer Prevention: Lowering your Risk

Latest Cancer News and Research

Polymeric nanomedicine strategies improve solid tumor immunotherapy outcomes

Solid tumors are not merely collections of malignant cells but complex ecosystems comprising tumor cells, stromal cells, and the extracellular matrix (ECM).

9 Oct 2026

Real time molecular movie unlocks secrets of penicillin biosynthesis

Researchers from the University of Oxford and international collaborators have revealed previously unseen rapid chemical stages in the formation of β-lactam antibiotics like penicillin, offering insights that can support future antibiotic development.

9 Oct 2026

FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) in combination with fluoropyrimidine and oxaliplatin chemotherapy, for the adjuvant treatment of patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR).

9 Oct 2026

Study explains why cancer immunity declines faster in males

Lutz Menzel, PhD, formerly of the Department of Radiation Oncology within the Mass General Brigham Cancer Institute, and Tim Padera, PhD, currently of the Mass General Brigham Cancer Institute, are the lead and senior authors of a paper published in Nature Aging, "Lymph node contraction links sex-biased naive CD8 T cell decline to compromised antigen recognition during middle age."

9 Oct 2026

Lynch syndrome patients rarely use aspirin for cancer prevention

According to international studies, taking Acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer - even at low doses. Researchers from the University Hospital Bonn (UKB), the University of Bonn, and the Center for Integrated Oncology (CIO) Bonn, in collaboration with the self-help organization SemiColon, have now found that these scientific findings have so far been insufficiently incorporated into clinical practice.

9 Oct 2026

Oncopeptides confirms blood-brain-barrier penetration based on data from first patients in glioblastoma Window-of-Opportunity (WoO) study

Oncopeptides AB (publ), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical Window-of-Opportunity (WoO) study, OP-701 (INSULA), evaluating its proprietary Peptide Drug Conjugate (PDC) platform in glioblastoma.

9 Oct 2026

New research unveils role of innate immune system in pancreatic cancer

Researchers from Adelaide University have demonstrated that blocking a specific immune system gene can reduce pancreatic cancer tumor formation.

9 Oct 2026

Infections caused 1 in 8 cancer cases worldwide in 2024, study finds

Infections drove 1 in 8 cancer cases worldwide in 2024, study finds.

9 Oct 2026

US counties with more medical debt see higher rates of several late-stage cancers

Higher medical debt is linked to more late-stage cancer diagnoses across U.S. counties.

9 Oct 2026

New iron deficiency guidelines raise key blood test cutoffs

ASH 2026 guidelines redefine iron deficiency diagnosis with higher ferritin thresholds, aiming for better detection and management across diverse populations.

9 Oct 2026

What young cancer survivors revealed about stress, exercise and friendship

Adolescent and young adult cancer survivors use exercise and social support to cope with stress, revealing insights for effective mental health interventions.

9 Oct 2026

$13.1 million grant backs bacterial therapies for resistant breast cancer

A scientist at Weill Cornell Medicine is working with colleagues at the University of Massachusetts Amherst on new, complementary research efforts engineering therapeutic Salmonella to target critical gaps in treatment for drug-resistant triple-negative breast cancers.

9 Oct 2026

SPRED2 coordinates three signaling pathways to suppress liver cancer stemness

Liver cancer is the fifth most commonly diagnosed cancer and the second leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 70-85% of primary liver cancers, and its five-year recurrence rate can reach 70-80%.

8 Oct 2026

DNA Typewriter tracks cell divisions and developmental decisions in mice

Scientists have succeeded in reconstructing the family tree of cells in a developing mouse embryo. They recorded cells' relationships, starting when the fertilized egg first split in two and ending after the body with organs took shape.

8 Oct 2026

Rare dendritic cells may promote immune tolerance in metastatic cancer

This study was co-led by Steven Blum, MD. Gary Reynolds, MD, PhD, Samuel Klempner, MD, and Alexandra-Chloé Villani, PhD, jointly supervised the work at the Krantz Family Center for Cancer Research within the Mass General Brigham Cancer Institute and the Mass General Brigham Center for Immunology & Inflammatory Diseases (CIID).

8 Oct 2026

Automated ultrasound offers reliable alternative for screening women with dense breasts

A new study in the Journal of the American College of Radiology, published by Elsevier, has found that automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) had similar cancer detection rates in women with dense breasts, while ABUS had a lower false-positive rate.

8 Oct 2026

Disrupted circadian rhythms may influence tumor immunity and cancer spread

Epidemiological studies link light at night (LAN), shift work, chronic jet lag (CJL), and core clock gene mutations to higher cancer risk and aggressive spread, especially in breast and colorectal cancer.

8 Oct 2026

NCCN collaborates with global organizations to launch tailored cancer guidelines for Philippines

The National Comprehensive Cancer Network (NCCN)-an alliance of leading academic cancer centers in the United States-is collaborating with several global organizations to publish new International Adaptations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the Philippines.

8 Oct 2026

Excess adiposity may alter the immune environment of airways to promote lung cancer

In a recent study of more than a thousand individuals, greater adiposity, or excessive body fat or fatty tissue, specifically in the abdomen, was associated with lung cancer.

8 Oct 2026

Combination therapy overcomes immunotherapy resistance in glioblastoma

Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to immunotherapy in glioblastoma.

8 Oct 2026